{"transactions":[{"id":3453721,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":155795,"kind":"person","name":"Darling Joseph G","position":1,"cik":"0001433556","reported_name":"Darling Joseph G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO; Director"}}],"security":"Common Stock","published_at":"2019-07-30T20:05:38.000Z","date":"2019-07-27","kind":"tax_withholding","acquired":false,"shares":2147,"price":55.85,"value":119909.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an aggregate of 2,147 shares of common stock retained by the Issuer to satisfy tax withholding obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the closing price of the ANIK common stock on July 26, 2019, the last trading day prior to the vesting of restricted shares giving rise to tax withholding obligations."}],"balance_after":20289,"source":{"system":"sec-edgar","filing":"0001171843-19-004978","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319004978/ownership.xml","form_type":"4"}},{"id":3624705,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":155795,"kind":"person","name":"Darling Joseph G","position":1,"cik":"0001433556","reported_name":"Darling Joseph G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO; Director"}}],"security":"Common Stock","published_at":"2019-03-01T13:30:39.000Z","date":"2019-02-28","kind":"purchase","acquired":true,"shares":1000,"price":33.2,"value":33200.0,"ownership":{"direct":true},"balance_after":22436,"source":{"system":"sec-edgar","filing":"0001171843-19-001414","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319001414/ownership.xml","form_type":"4"}},{"id":3627458,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":155795,"kind":"person","name":"Darling Joseph G","position":1,"cik":"0001433556","reported_name":"Darling Joseph G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO; Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-28T21:32:58.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":7609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 24, 2018, the date the Compensation Committee of the Company granted these performance-based stock option awards (the \"Performance Grant\"). Please also see notes 3 and 4."},{"field":"date","element":"transactionDate","label":"F3","text":"On February 27, 2019, the Compensation Committee determined and certified that 53.2% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 2 and 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options vest in four equal installments on the following dates: February 27, 2019, January 1, 2020, January 1, 2021, and January 1, 2022."}],"balance_after":7609,"derivative":{"exercise_price":61.47,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":7609},"source":{"system":"sec-edgar","filing":"0001171843-19-001386","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319001386/ownership.xml","form_type":"4"}},{"id":3627457,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":155795,"kind":"person","name":"Darling Joseph G","position":1,"cik":"0001433556","reported_name":"Darling Joseph G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO; Director"}}],"security":"Restricted Stock Unit","published_at":"2019-02-28T21:32:58.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020, provided that the first installment of shares hereunder shall be delivered upon the first to occur of Mr. Darling's (a) death, (b) disability, (c) separation from service (as defined by the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (the \"Plan\")), or (d) a Change in Control (as defined by the Plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020, provided that the first installment of shares hereunder shall be delivered upon the first to occur of Mr. Darling's (a) death, (b) disability, (c) separation from service (as defined by the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (the \"Plan\")), or (d) a Change in Control (as defined by the Plan)."}],"balance_after":63000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001171843-19-001386","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319001386/ownership.xml","form_type":"4"}},{"id":3999422,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":155795,"kind":"person","name":"Darling Joseph G","position":1,"cik":"0001433556","reported_name":"Darling Joseph G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO; Director"}}],"security":"Common Stock","published_at":"2018-03-13T20:05:42.000Z","date":"2018-03-09","kind":"tax_withholding","acquired":false,"shares":548,"price":53.49,"value":29312.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 548 shares of common stock retained by the Issuer to satisfy tax withholding obligations."}],"balance_after":21436,"source":{"system":"sec-edgar","filing":"0001171843-18-001902","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318001902/form4.xml","form_type":"4"}},{"id":3999421,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":155795,"kind":"person","name":"Darling Joseph G","position":1,"cik":"0001433556","reported_name":"Darling Joseph G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO; Director"}}],"security":"Common Stock","published_at":"2018-03-13T20:05:42.000Z","date":"2018-03-09","kind":"grant","acquired":true,"shares":7478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted stock awards vest in four equal annual installments on March 9, 2018, March 9, 2019, March 9, 2020, and March 9, 2021."}],"balance_after":21984,"source":{"system":"sec-edgar","filing":"0001171843-18-001902","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318001902/form4.xml","form_type":"4"}},{"id":4088831,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":155795,"kind":"person","name":"Darling Joseph G","position":1,"cik":"0001433556","reported_name":"Darling Joseph G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-26T21:06:59.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":21400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in four equal annual installments beginning January 24, 2019."}],"balance_after":21400,"derivative":{"exercise_price":61.47,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":21400},"source":{"system":"sec-edgar","filing":"0001171843-18-000690","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318000690/formfour.xml","form_type":"4"}},{"id":4248815,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":155795,"kind":"person","name":"Darling Joseph G","position":1,"cik":"0001433556","reported_name":"Darling Joseph G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-31T20:10:22.000Z","date":"2017-07-27","kind":"grant","acquired":true,"shares":41609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in three equal annual installments beginning July 27, 2018."}],"balance_after":41609,"derivative":{"exercise_price":51.7,"expiration_date":"2027-07-27","underlying":"Common Stock","underlying_shares":41609},"source":{"system":"sec-edgar","filing":"0001171843-17-004467","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317004467/formfour.xml","form_type":"4"}},{"id":4248814,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":155795,"kind":"person","name":"Darling Joseph G","position":1,"cik":"0001433556","reported_name":"Darling Joseph G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2017-07-31T20:10:22.000Z","date":"2017-07-27","kind":"grant","acquired":true,"shares":14506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted stock awards vest in three equal annual installments beginning July 27, 2018."}],"balance_after":14506,"source":{"system":"sec-edgar","filing":"0001171843-17-004467","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317004467/formfour.xml","form_type":"4"}}]}